about
Constellation pharmacology: a new paradigm for drug discoveryLessons from the past and charting the future of marine natural products drug discovery and chemical biologyA pain-inducing centipede toxin targets the heat activation machinery of nociceptor TRPV1.Characterization of a venom peptide from a crassispirid gastropodConantokins derived from the Asprella clade impart conRl-B, an N-methyl d-aspartate receptor antagonist with a unique selectivity profile for NR2B subunits.Elucidation of the molecular envenomation strategy of the cone snail Conus geographus through transcriptome sequencing of its venom duct.δ-Conotoxins synthesized using an acid-cleavable solubility tag approach reveal key structural determinants for NaV subtype selectivity.Lost but making progress--Where will new analgesic drugs come from?Marine natural products acting on the acetylcholine-binding protein and nicotinic receptors: from computer modeling to binding studies and electrophysiology.High-Affinity α-Conotoxin PnIA Analogs Designed on the Basis of the Protein Surface Topography Method.Ion channel drug discovery: challenges and future directions.Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisPhage therapy: eco-physiological pharmacology.Ribosomally synthesized and post-translationally modified peptide natural product discovery in the genomic era.Combination Drug Therapy for Pain following Chronic Spinal Cord Injury.Aspersymmetide A, a New Centrosymmetric Cyclohexapeptide from the Marine-Derived Fungus Aspergillus versicolor.Bioactive Compounds Isolated from Neglected Predatory Marine Gastropods.
P2860
Q26823685-E6F22136-4529-47A5-B656-2B2B249F7435Q26863108-414A9FDE-43BA-4B64-9D13-05EBB6DF6919Q27322813-EE17164D-643E-411E-967D-DFC0C0B3596DQ30460390-00A59F40-7CB7-481E-9C6C-84ADBDB1F5E5Q34129177-B765BACA-2C1D-42B4-AF16-1E0B91A289E0Q34319949-12DA6C67-5830-458A-B084-DA1028FF6C54Q34737924-588AFC38-345B-45B0-891B-C1F6072E8E23Q35058471-A00E79F5-03A7-4F7B-9DF5-FAF7D0C8F8D8Q35136084-594F7785-2007-4A9F-A90E-747A41808EF4Q37411892-E689C5C0-1A1D-4B41-AF34-470563CA58E5Q37998135-277C0D21-CE71-47E7-86BC-EFCD2915D697Q38123670-B20B3CFB-10B0-4BD9-B890-9C530E28D5A6Q38230407-F20EC62E-AC87-4437-81F2-F58C965AB383Q38928841-AA4A5E71-15D8-4341-9498-C5035DA6B7CBQ42548830-AE470868-D6F7-44D7-A585-1A0D7E4DC6DAQ46256225-A04E4E99-032A-42F3-88C1-14FD8A05D60EQ55056760-BA203EBB-F190-49A8-9946-F8725E2BF6B3
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Natural products and ion channel pharmacology
@ast
Natural products and ion channel pharmacology
@en
Natural products and ion channel pharmacology
@nl
type
label
Natural products and ion channel pharmacology
@ast
Natural products and ion channel pharmacology
@en
Natural products and ion channel pharmacology
@nl
prefLabel
Natural products and ion channel pharmacology
@ast
Natural products and ion channel pharmacology
@en
Natural products and ion channel pharmacology
@nl
P2860
P356
P1476
Natural products and ion channel pharmacology
@en
P2093
Baldomero M Olivera
Russell W Teichert
P2860
P304
P356
10.4155/FMC.10.31
P577
2010-05-01T00:00:00Z